OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Rodin Therapeutics

3 Projects | 2 Researchers | $419,942 Invested

2015

Rodin Therapeutics

Berkley Lynch, PhD

Selective HDAC2 Inhibitors for the Treatment of Cognitive Deficits in Alzheimer's Disease - Year 2, Part 2

  • Funding Amount: $161,759
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Status: Closed

2015

Rodin Therapeutics

Martin Jefson, PhD

Selective HDAC2 Inhibitors for the Treatment of Cognitive Deficits in Alzheimer's Disease - Year 2

  • Funding Amount: $75,683
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Target: Epigenetics
  • Status: Closed

2013

Rodin Therapeutics

Martin Jefson, PhD

Selective HDAC2 Inhibitors for the Treatment of Cognitive Deficits in Alzheimer's Disease

  • Funding Amount: $182,500
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Target: Epigenetics
  • Status: Closed